Cargando…

N‐(Anilinoethyl)amide Melatonergic Ligands with Improved Water Solubility and Metabolic Stability

The MT(2)‐selective melatonin receptor ligand UCM765 (N‐(2‐((3‐methoxyphenyl)(phenyl)amino)ethyl)acetamide), showed interesting sleep inducing, analgesic and anxiolytic properties in rodents, but suffers from low water solubility and modest metabolic stability. To overcome these limitations, differe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferlenghi, Francesca, Mari, Michele, Gobbi, Gabriella, Elisi, Gian Marco, Mor, Marco, Rivara, Silvia, Vacondio, Federica, Bartolucci, Silvia, Bedini, Annalida, Fanini, Fabiola, Spadoni, Gilberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Full Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518537/ https://www.ncbi.nlm.nih.gov/pubmed/34213063 http://dx.doi.org/10.1002/cmdc.202100405

Ejemplares similares

Chiral Recognition of Flexible Melatonin Receptor Ligands Induced by Conformational Equilibria
por: Elisi, Gian Marco, et al.
Publicado: (2020)

Cardioprotective effects of fatty acid amide hydrolase inhibitor URB694, in a rodent model of trait anxiety
por: Carnevali, Luca, et al.
Publicado: (2015)

Homology Models of Melatonin Receptors: Challenges and Recent Advances
por: Pala, Daniele, et al.
Publicado: (2013)

Synthesis and Characterization of New Bivalent Agents as Melatonin- and Histamine H(3)-Ligands
por: Pala, Daniele, et al.
Publicado: (2014)

Antiproliferative and pro-apoptotic activity of melatonin analogues on melanoma and breast cancer cells
por: Gatti, Giuliana, et al.
Publicado: (2017)

Free-Energy Simulations Support a Lipophilic Binding Route for Melatonin Receptors
por: Elisi, Gian Marco, et al.
Publicado: (2021)

New classes of potent heparanase inhibitors from ligand-based virtual screening
por: Pala, Daniele, et al.
Publicado: (2020)

Melatonin MT(1) and MT(2) Receptors Exhibit Distinct Effects in the Modulation of Body Temperature across the Light/Dark Cycle
por: López-Canul, Martha, et al.
Publicado: (2019)

Melatonergic drugs in development
por: Carocci, Alessia, et al.
Publicado: (2014)

1-[(2-Anilinoethyl)iminiomethyl]-2-naphtholate
por: Hao, Yu-Mei
Publicado: (2009)

Agomelatine: A novel melatonergic antidepressant
por: Manikandan, S
Publicado: (2010)

Melatonin and melatonergic drugs in sleep disorders
por: Kim, Hyung Ki, et al.
Publicado: (2022)

Free-energy studies reveal a possible mechanism for oxidation-dependent inhibition of MGL
por: Scalvini, Laura, et al.
Publicado: (2016)

Glioblastoma chemoresistance: roles of the mitochondrial melatonergic pathway
por: Anderson, George
Publicado: (2020)

Synthesis and Fluorescence Properties of 4-Cyano and 4-Formyl Melatonin as Putative Melatoninergic Ligands
por: Bartolucci, Silvia, et al.
Publicado: (2023)

Metabolic Soft Spot and Pharmacokinetics: Functionalization of C-3 Position of an Eph–Ephrin Antagonist Featuring a Bile Acid Core as an Effective Strategy to Obtain Oral Bioavailability in Mice
por: Ferlenghi, Francesca, et al.
Publicado: (2021)

PT628. First in class melatonin MT2 receptors agonists for neuropathic pain
por: Gobbi, Gabriella, et al.
Publicado: (2016)

Depression Pathophysiology: Astrocyte Mitochondrial Melatonergic Pathway as Crucial Hub
por: Anderson, George
Publicado: (2022)

{6-[(2-Anilinoethyl)iminomethyl]-2-ethoxyphenolato}(thiocyanato-κN)copper(II)
por: Wang, Chen-Yi, et al.
Publicado: (2010)

Amino Acid Derivatives as Palmitoylethanolamide Prodrugs: Synthesis, In Vitro Metabolism and In Vivo Plasma Profile in Rats
por: Vacondio, Federica, et al.
Publicado: (2015)

Assessment of Melatonergics in Prevention of Delirium: A Systematic Review and Meta-Analysis
por: Zhu, Yibing, et al.
Publicado: (2020)

Acute toxicity and genotoxicity studies on new melatonergic antidepressant GW117
por: Gao, Mei, et al.
Publicado: (2023)

Molecular Determinants of EphA2 and EphB2 Antagonism Enable the Design of Ligands with Improved Selectivity
por: Guidetti, Lorenzo, et al.
Publicado: (2023)

A Systematic, Updated Review on the Antidepressant Agomelatine Focusing on its Melatonergic Modulation
por: Fornaro, Michele, et al.
Publicado: (2010)

The Melatonergic System in Mood and Anxiety Disorders and the Role of Agomelatine: Implications for Clinical Practice
por: De Berardis, Domenico, et al.
Publicado: (2013)

Mechanistic Modeling of Monoglyceride Lipase Covalent Modification Elucidates the Role of Leaving Group Expulsion and Discriminates Inhibitors with High and Low Potency
por: Galvani, Francesca, et al.
Publicado: (2022)

Palladium Catalyst Recycling for Heck‐Cassar‐Sonogashira Cross‐Coupling Reactions in Green Solvent/Base Blend
por: Fantoni, Tommaso, et al.
Publicado: (2021)

Melatonin and Melatonergic Influence on Neuronal Transcription Factors: Implications for the Development of Novel Therapies for Neurodegenerative Disorders
por: Onaolapo, O.J., et al.
Publicado: (2020)

Assessment of melatonergics in prevention of delirium in critically ill patients: A protocol for systematic review and meta-analysis
por: Zhu, Yibing, et al.
Publicado: (2020)

Melatonergic signalling instructs transcriptional inhibition of IFNGR2 to lessen interleukin‐1β‐dependent inflammation
por: Xia, Yaoyao, et al.
Publicado: (2022)

Melatonergic Receptors (Mt1/Mt2) as a Potential Additional Target of Novel Drugs for Depression
por: Boiko, Dmytro I., et al.
Publicado: (2022)

An Optimized Workflow for the Discovery of New Antimicrobial Compounds Targeting Bacterial RNA Polymerase Complex Formation
por: Caputo, Alessia, et al.
Publicado: (2022)

Critical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adults
por: Howland, Robert H
Publicado: (2009)

Tumor Microenvironment and Metabolism: Role of the Mitochondrial Melatonergic Pathway in Determining Intercellular Interactions in a New Dynamic Homeostasis
por: Anderson, George
Publicado: (2022)

Kinetic analysis and molecular modeling of the inhibition mechanism of roneparstat (SST0001) on human heparanase
por: Pala, Daniele, et al.
Publicado: (2016)

Repurposing of Drugs Targeting YAP-TEAD Functions
por: Elisi, Gian Marco, et al.
Publicado: (2018)

Comparative Analysis of Virtual Screening Approaches in the Search for Novel EphA2 Receptor Antagonists
por: Callegari, Donatella, et al.
Publicado: (2015)

Left Ventricular Hypertrophy: Roles of Mitochondria CYP1B1 and Melatonergic Pathways in Co-Ordinating Wider Pathophysiology
por: Anderson, George, et al.
Publicado: (2019)

Rhythmic expression of the melatonergic biosynthetic pathway and its differential modulation in vitro by LPS and IL10 in bone marrow and spleen
por: Córdoba-Moreno, Marlina O., et al.
Publicado: (2020)

Integrative Pan-Cancer Analysis Reveals Decreased Melatonergic Gene Expression in Carcinogenesis and RORA as a Prognostic Marker for Hepatocellular Carcinoma
por: Zou, Yi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tmv37tm2p0p0jkn7uitlrt52d2